Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Int J Drug Policy. 2019 Jul 23;73:81–87. doi: 10.1016/j.drugpo.2019.07.005

Table 4.

Responses to Adverse Outcomes

Asked Someone for Help, % Felt Needed to Visit ED or Hospital, % Went to ED or Hospital, %
Alcohol 39.2 9.9 4.6
Marijuana 29.7 9.3 1.2
Ecstasy/MDMA/Molly 37.2 14.0 7.0
Cocaine 22.7 11.4 4.5
LSD 41.3 21.7 6.5
Shrooms 25.0 12.5 0.0
Ketamine 43.8 3.1 0.0
Poppers 7.7 7.7 0.0
Amphetamine 17.2 3.4 3.4
Prescription Opioids 31.0 23.8 14.3
Benzodiazepines 22.2 5.6 0.0
GHB 20.0 0.0 0.0
Synthetic Cathinones ("Bath Salts") 57.1 71.4 57.1
Methamphetamine 12.5 12.5 12.5
DMT 0.0 25.0 25.0
Synthetic Cannabinoids 0.0 0.0 0.0
2C Series 0.0 33.3 33.3
Other MDx 50.0 25.0 25.0
PCP 0.0 0.0 0.0
Novel Dissociatives 25.0 25.0 0.0
Unknown powder 50.0 0.0 0.0
NBOMe 100.0 0.0 0.0
Fentanyl, its Analogs, & Other New Opioids 25.0 50.0 25.0
Heroin 33.3 16.7 16.7

Note. ED = emergency department.